Shares of Carl Zeiss Meditec AG (ETR:AFX) have received an average recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is €84.06 ($97.75).
AFX has been the subject of several recent analyst reports. Nord/LB set a €92.00 ($106.98) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Wednesday, May 8th. HSBC set a €98.00 ($113.95) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Wednesday. Berenberg Bank set a €93.00 ($108.14) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Wednesday, July 17th. Independent Research set a €88.00 ($102.33) target price on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a report on Wednesday, July 17th. Finally, Deutsche Bank set a €89.00 ($103.49) price objective on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Monday.
Carl Zeiss Meditec stock traded down €2.90 ($3.37) during trading hours on Friday, hitting €97.90 ($113.84). The stock had a trading volume of 133,330 shares, compared to its average volume of 94,405. The company has a debt-to-equity ratio of 4.55, a current ratio of 4.11 and a quick ratio of 3.09. The company has a market cap of $8.76 billion and a PE ratio of 68.27. Carl Zeiss Meditec has a 12-month low of €60.25 ($70.06) and a 12-month high of €104.30 ($121.28). The stock has a 50-day simple moving average of €93.22.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Featured Story: What strategies should day traders use to execute a trade?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.